Overexpression of Adenosine A2A receptors in rats: effects on depression, locomotion, and anxiety
Copyright: © 2014 Coelho, Alves, Canas, Valadas, Shmidt, Batalha, Ferreira, Ribeiro, Bader, Cunha, do Couto and Lopes. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, p...
Saved in:
Published in | Frontiers in psychiatry Vol. 5; p. 67 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers
2014
Frontiers Media S.A |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Copyright: © 2014 Coelho, Alves, Canas, Valadas, Shmidt, Batalha, Ferreira, Ribeiro, Bader, Cunha, do Couto and Lopes. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Adenosine A2A receptors (A2AR) are a sub-type of receptors enriched in basal ganglia, activated by the neuromodulator adenosine, which interact with dopamine D2 receptors. Although this reciprocal antagonistic interaction is well-established in motor function, the outcome in dopamine-related behaviors remains uncertain, in particular in depression and anxiety. We have demonstrated an upsurge of A2AR associated to aging and chronic stress. Furthermore, Alzheimer's disease patients present A2AR accumulation in cortical areas together with depressive signs. We now tested the impact of overexpressing A2AR in forebrain neurons on dopamine-related behavior, namely depression. Adult male rats overexpressing human A2AR under the control of CaMKII promoter [Tg(CaMKII-hA2AR)] and aged-matched wild-types (WT) of the same strain (Sprague-Dawley) were studied. The forced swimming test (FST), sucrose preference test (SPT), and the open-field test (OFT) were performed to evaluate behavioral despair, anhedonia, locomotion, and anxiety. Tg(CaMKII-hA2AR) animals spent more time floating and less time swimming in the FST and presented a decreased sucrose preference at 48 h in the SPT. They also covered higher distances in the OFT and spent more time in the central zone than the WT. The results indicate that Tg(CaMKII-hA2AR) rats exhibit depressive-like behavior, hyperlocomotion, and altered exploratory behavior. This A2AR overexpression may explain the depressive signs found in aging, chronic stress, and Alzheimer's disease.
Joana E. Coelho, Vânia L. Batalha and Diana G. Ferreira were supported by a grant from Fundação para a Ciência e Tecnologia (FCT); Paula M. Canas and Rodrigo A. Cunha were supported by FCT (PTDC/SAU-NSC/122254/2010) and Defense Advanced Research Projects Agency (DARPA, grant 09-68-ESR- FP-010). Luísa V. Lopes is an Investigator FCT, funded by Fundação para a Ciência e Tecnologia (PTDC-099853/2009) and Bial. |
---|---|
AbstractList | Adenosine A2A receptors (A2AR) are a sub-type of receptors enriched in basal ganglia, activated by the neuromodulator adenosine, which interact with dopamine D2 receptors. Although this reciprocal antagonistic interaction is well established in motor function, the outcome in dopamine-related behaviors remains uncertain, in particular in depression and anxiety. We have demonstrated an upsurge of A2AR associated to aging and chronic stress. Furthermore, Alzheimer’s disease patients present A2AR accumulation in cortical areas together with depressive signs. We now tested the impact of overexpressing A2AR in forebrain neurons on dopamine related behavior, namely depression. Adult male rats overexpressing human A2AR under the control of CaMKII promoter [Tg(CaMKII-hA2AR)] and aged-matched wild-types (WT) of the same strain (Sprague-Dawley) were studied. The forced swimming test (FST), sucrose preference test (SPT) and the open-field test (OFT) were performed to evaluate behavioral despair, anhedonia, locomotion and anxiety. Tg(CaMKII-hA2AR) animals spent more time floating and less time swimming in the FST and presented a decreased sucrose preference at 48h in the SPT. They also covered higher distances in the OFT and spent more time in the central zone than the WT. The results indicate that Tg(CaMKII-hA2AR) rats exhibit depressive-like behavior, hyperlocomotion and altered exploratory behavior. This A2AR overexpression may explain the depressive signs found in aging, chronic stress and Alzheimer’s disease. Adenosine A 2A receptors (A 2A R) are a sub-type of receptors enriched in basal ganglia, activated by the neuromodulator adenosine, which interact with dopamine D 2 receptors. Although this reciprocal antagonistic interaction is well-established in motor function, the outcome in dopamine-related behaviors remains uncertain, in particular in depression and anxiety. We have demonstrated an upsurge of A 2A R associated to aging and chronic stress. Furthermore, Alzheimer’s disease patients present A 2A R accumulation in cortical areas together with depressive signs. We now tested the impact of overexpressing A 2A R in forebrain neurons on dopamine-related behavior, namely depression. Adult male rats overexpressing human A 2A R under the control of CaMKII promoter [Tg(CaMKII-hA2AR)] and aged-matched wild-types (WT) of the same strain (Sprague-Dawley) were studied. The forced swimming test (FST), sucrose preference test (SPT), and the open-field test (OFT) were performed to evaluate behavioral despair, anhedonia, locomotion, and anxiety. Tg(CaMKII-hA2AR) animals spent more time floating and less time swimming in the FST and presented a decreased sucrose preference at 48 h in the SPT. They also covered higher distances in the OFT and spent more time in the central zone than the WT. The results indicate that Tg(CaMKII-hA2AR) rats exhibit depressive-like behavior, hyperlocomotion, and altered exploratory behavior. This A 2A R overexpression may explain the depressive signs found in aging, chronic stress, and Alzheimer’s disease. Adenosine A2A receptors (A2AR) are a sub-type of receptors enriched in basal ganglia, activated by the neuromodulator adenosine, which interact with dopamine D2 receptors. Although this reciprocal antagonistic interaction is well-established in motor function, the outcome in dopamine-related behaviors remains uncertain, in particular in depression and anxiety. We have demonstrated an upsurge of A2AR associated to aging and chronic stress. Furthermore, Alzheimer's disease patients present A2AR accumulation in cortical areas together with depressive signs. We now tested the impact of overexpressing A2AR in forebrain neurons on dopamine-related behavior, namely depression. Adult male rats overexpressing human A2AR under the control of CaMKII promoter [Tg(CaMKII-hA2AR)] and aged-matched wild-types (WT) of the same strain (Sprague-Dawley) were studied. The forced swimming test (FST), sucrose preference test (SPT), and the open-field test (OFT) were performed to evaluate behavioral despair, anhedonia, locomotion, and anxiety. Tg(CaMKII-hA2AR) animals spent more time floating and less time swimming in the FST and presented a decreased sucrose preference at 48 h in the SPT. They also covered higher distances in the OFT and spent more time in the central zone than the WT. The results indicate that Tg(CaMKII-hA2AR) rats exhibit depressive-like behavior, hyperlocomotion, and altered exploratory behavior. This A2AR overexpression may explain the depressive signs found in aging, chronic stress, and Alzheimer's disease. Copyright: © 2014 Coelho, Alves, Canas, Valadas, Shmidt, Batalha, Ferreira, Ribeiro, Bader, Cunha, do Couto and Lopes. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. Adenosine A2A receptors (A2AR) are a sub-type of receptors enriched in basal ganglia, activated by the neuromodulator adenosine, which interact with dopamine D2 receptors. Although this reciprocal antagonistic interaction is well-established in motor function, the outcome in dopamine-related behaviors remains uncertain, in particular in depression and anxiety. We have demonstrated an upsurge of A2AR associated to aging and chronic stress. Furthermore, Alzheimer's disease patients present A2AR accumulation in cortical areas together with depressive signs. We now tested the impact of overexpressing A2AR in forebrain neurons on dopamine-related behavior, namely depression. Adult male rats overexpressing human A2AR under the control of CaMKII promoter [Tg(CaMKII-hA2AR)] and aged-matched wild-types (WT) of the same strain (Sprague-Dawley) were studied. The forced swimming test (FST), sucrose preference test (SPT), and the open-field test (OFT) were performed to evaluate behavioral despair, anhedonia, locomotion, and anxiety. Tg(CaMKII-hA2AR) animals spent more time floating and less time swimming in the FST and presented a decreased sucrose preference at 48 h in the SPT. They also covered higher distances in the OFT and spent more time in the central zone than the WT. The results indicate that Tg(CaMKII-hA2AR) rats exhibit depressive-like behavior, hyperlocomotion, and altered exploratory behavior. This A2AR overexpression may explain the depressive signs found in aging, chronic stress, and Alzheimer's disease. Joana E. Coelho, Vânia L. Batalha and Diana G. Ferreira were supported by a grant from Fundação para a Ciência e Tecnologia (FCT); Paula M. Canas and Rodrigo A. Cunha were supported by FCT (PTDC/SAU-NSC/122254/2010) and Defense Advanced Research Projects Agency (DARPA, grant 09-68-ESR- FP-010). Luísa V. Lopes is an Investigator FCT, funded by Fundação para a Ciência e Tecnologia (PTDC-099853/2009) and Bial. |
Author | Bader, Michael Canas, Paula M. Shmidt, Tatiana Simões do Couto, Frederico Coelho, Joana Batalha, Vânia Nascimento Alves, Pedro Ribeiro, Joaquim Lopes, Luisa Valadas, Jorge S. Ferreira, Diana G. Cunha, Rodrigo A. |
AuthorAffiliation | 5 Max-Delbrück-Center for Molecular Medicine (MDC) , Berlin , Germany 4 Faculty of Medicine, University of Coimbra , Coimbra , Portugal 1 Faculty of Medicine of Lisbon, Instituto de Medicina Molecular, University of Lisbon , Lisbon , Portugal 2 Faculty of Medicine of Lisbon, Institute of Pharmacology and Neurosciences, University of Lisbon , Lisbon , Portugal 3 CNC-Center for Neurosciences and Cell Biology, University of Coimbra , Coimbra , Portugal |
AuthorAffiliation_xml | – name: 2 Faculty of Medicine of Lisbon, Institute of Pharmacology and Neurosciences, University of Lisbon , Lisbon , Portugal – name: 3 CNC-Center for Neurosciences and Cell Biology, University of Coimbra , Coimbra , Portugal – name: 4 Faculty of Medicine, University of Coimbra , Coimbra , Portugal – name: 1 Faculty of Medicine of Lisbon, Instituto de Medicina Molecular, University of Lisbon , Lisbon , Portugal – name: 5 Max-Delbrück-Center for Molecular Medicine (MDC) , Berlin , Germany |
Author_xml | – scopusid: 7101840699 sequence: 1 givenname: Joana orcidid: 0000-0002-3964-6197 surname: Coelho fullname: Coelho, Joana – sequence: 2 givenname: Pedro orcidid: 0000-0001-5740-5904 surname: Nascimento Alves fullname: Nascimento Alves, Pedro – sequence: 3 fullname: Canas, Paula M. – sequence: 4 givenname: Jorge S. orcidid: 0000-0002-2126-9485 surname: Valadas fullname: Valadas, Jorge S. – sequence: 5 fullname: Shmidt, Tatiana – sequence: 6 givenname: Vânia orcidid: 0000-0001-6657-1111 surname: Batalha fullname: Batalha, Vânia – sequence: 7 fullname: Ferreira, Diana G. – scopusid: 35498669400 sequence: 8 givenname: Joaquim orcidid: 0000-0002-9330-3507 surname: Ribeiro fullname: Ribeiro, Joaquim – sequence: 9 fullname: Bader, Michael – sequence: 10 fullname: Cunha, Rodrigo A. – scopusid: 14621494400 sequence: 11 givenname: Frederico orcidid: 0000-0002-3916-2598 surname: Simões do Couto fullname: Simões do Couto, Frederico – scopusid: 7102509159 sequence: 12 givenname: Luisa orcidid: 0000-0001-8367-3005 surname: Lopes fullname: Lopes, Luisa |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24982640$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkc1PGzEQxS1EBZRy76na3npoUn_H7qFShGiLhMSlPVte75gabeyt7UTkv8dJAMHB8sjzmzdPfu_RcUwREPpI8Jwxpb_5qWzrnGLC5xhjuThCZ0RKPsOS4-NX9Sm6KOW-IZhpzaQ4QaeUa0Vb6wzZ2w1keJgylBJS7JLvlgPEVEKEbkmXXQYHU025dCF22dbyvQPvwdXSNXyA58mv3ZhcWqW6r20c2nkIULcf0DtvxwIXT_c5-vvz6s_l79nN7a_ry-XNzHGpFzOlBFjwmEDfzHnSy8FTpjj3WghPRM8UIdp7S3qiLKZUMc6V1JYS2Ust2Tm6PugOyd6bKYeVzVuTbDD7h5TvjM01uBGMdIIo6mnPNOXCUesXUhKmscK8x4NoWj8OWtO6X8HgINZsxzeibzsx_DN3aWM4FkLJnZkvTwI5_V9DqWYVioNxtBHSuhgiOKVackUbig-oy6mUDP5lDcFmF7TZB212QZt90G3k02t7LwPPsTbg8wHIztrJZNiEUm1bi7kgRpD2Z-wRa82w8A |
CitedBy_id | crossref_primary_10_1007_s11302_018_9609_4 crossref_primary_10_1016_j_celrep_2021_109574 crossref_primary_10_1016_j_neuropharm_2022_108977 crossref_primary_10_1038_mp_2017_188 crossref_primary_10_29254_2077_4214_2022_4_167_76_83 crossref_primary_10_2217_epi_2023_0351 crossref_primary_10_1038_nn_4648 crossref_primary_10_1038_s41380_018_0110_9 crossref_primary_10_1016_j_brainresbull_2019_06_016 crossref_primary_10_3389_fnmol_2018_00475 crossref_primary_10_1038_s41392_021_00553_z crossref_primary_10_1089_caff_2019_0022 crossref_primary_10_1038_mp_2016_173 crossref_primary_10_2174_1573406416666191227120425 crossref_primary_10_1007_s12640_022_00550_2 crossref_primary_10_1016_j_pbb_2015_05_005 crossref_primary_10_1111_jnc_14841 crossref_primary_10_1080_14728222_2020_1758667 crossref_primary_10_3390_biology12040559 crossref_primary_10_1080_07388551_2023_2231139 crossref_primary_10_3390_brainsci10030160 crossref_primary_10_1007_s12035_015_9660_x crossref_primary_10_1111_jnc_14816 crossref_primary_10_3389_fncel_2019_00589 crossref_primary_10_1007_s12035_015_9270_7 crossref_primary_10_3390_ph15111323 crossref_primary_10_4236_abb_2023_1412037 crossref_primary_10_3389_fncel_2015_00521 crossref_primary_10_3389_fpsyt_2019_00363 crossref_primary_10_1007_s11302_016_9551_2 crossref_primary_10_1016_j_neuropharm_2019_05_003 crossref_primary_10_1016_j_phrs_2019_104338 crossref_primary_10_1016_j_ynstr_2023_100543 crossref_primary_10_1016_j_physbeh_2016_11_030 crossref_primary_10_1038_s41398_020_01183_9 crossref_primary_10_1038_s41598_022_26808_5 crossref_primary_10_3390_brainsci7030030 crossref_primary_10_1177_02698811211058975 crossref_primary_10_1016_j_ejphar_2021_174364 crossref_primary_10_1111_bph_16216 crossref_primary_10_1155_2015_575063 crossref_primary_10_1089_caff_2020_0009 crossref_primary_10_1007_s11302_020_09694_2 crossref_primary_10_1007_s12035_022_03001_3 crossref_primary_10_1016_j_neuropharm_2022_109371 crossref_primary_10_1016_j_phrs_2020_105363 crossref_primary_10_1007_s12035_023_03441_5 crossref_primary_10_1016_j_jneumeth_2022_109707 crossref_primary_10_1016_j_pharmthera_2021_107821 crossref_primary_10_1016_j_pnpbp_2019_109776 crossref_primary_10_2174_1381612825666190716113444 crossref_primary_10_1139_cjpp_2022_0098 crossref_primary_10_1111_jnc_13109 crossref_primary_10_3390_ijms23031219 crossref_primary_10_2174_1389201022666211012102501 crossref_primary_10_1016_j_bbi_2019_05_025 crossref_primary_10_1038_s41392_024_01738_y crossref_primary_10_3389_fncel_2021_639322 crossref_primary_10_3390_cells9071739 crossref_primary_10_1080_00207454_2020_1754213 crossref_primary_10_1016_j_pbb_2023_173573 crossref_primary_10_3389_fnins_2021_702581 crossref_primary_10_1007_s12640_018_9959_2 crossref_primary_10_1111_jnc_13421 crossref_primary_10_1007_s11064_021_03263_8 |
Cites_doi | 10.1176/appi.ajp.163.9.1594 10.1038/npp.2008.72 10.1007/s00702-010-0454-z 10.1111/bph.12234 10.1038/nrn2652 10.1523/JNEUROSCI.1538-06.2006 10.1016/j.bbr.2011.06.021 10.1023/A:1014912128311 10.1016/j.biopsych.2005.05.019 10.1016/j.biopsych.2013.05.003 10.1016/j.bbr.2005.01.005 10.1046/j.1471-4159.2001.00389.x 10.1038/41771 10.1016/j.bbr.2009.05.036 10.1016/j.prostaglandins.2008.10.001 10.1007/BF01277656 10.1111/j.1471-4159.2004.02887.x 10.1016/S0165-6147(02)02017-5 10.1111/j.1476-5381.1995.tb16421.x 10.1016/j.ejphar.2005.07.025 10.1038/mp.2012.8 10.1093/schbul/sbp006 10.1038/sj.npp.1300959 10.1016/j.tins.2007.03.006 10.1111/j.1528-1167.2010.02700.x 10.1038/sj.npp.1300876 10.1016/S0149-7634(01)00011-2 10.1016/S0149-7634(05)80192-7 10.1016/j.nlm.2006.05.004 10.1016/S0166-2236(97)01096-5 10.1038/sj.npp.1300532 10.1038/sj.npp.1300167 10.1016/S0014-2999(03)01272-X 10.1016/j.neulet.2004.12.012 10.1016/j.ejphar.2009.06.018 10.1038/sj.npp.1300852 10.2174/1874082001004020093 10.1016/j.pnpbp.2008.01.012 10.1111/j.1750-3639.2007.00112.x 10.1016/S0304-3940(00)01371-9 10.1007/BF02244188 10.1016/j.ejphar.2012.08.020 10.1176/appi.ajp.2008.08081201 10.1212/01.WNL.0000095220.87550.F6 10.1016/j.tips.2008.07.005 10.1016/j.npep.2009.12.002 10.1016/j.neuroscience.2005.01.054 10.1523/JNEUROSCI.4215-09.2009 10.1016/S0092-8674(02)00763-8 10.1124/jpet.103.062463 10.1111/j.1471-4159.2009.05876.x 10.1001/archneur.61.5.641 10.1523/JNEUROSCI.5066-06.2007 10.1111/j.1460-9568.2011.07719.x 10.1016/j.neubiorev.2005.04.016 10.1038/266730a0 10.1007/s00213-005-0284-0 10.1016/S0306-4522(02)00080-5 10.1523/JNEUROSCI.3574-05.2006 10.1038/sj.npp.1300232 10.1124/jpet.107.123844 10.1002/glia.22290 10.1016/j.physbeh.2007.05.034 10.1016/j.bbr.2005.03.009 10.1016/j.neubiorev.2005.03.008 10.1016/S0301-0082(02)00155-7 10.1016/j.neuroimage.2009.01.058 10.1007/s00213-009-1608-2 10.1016/j.bbr.2010.03.003 10.1101/SQB.1996.061.01.024 10.1016/j.ejphar.2007.01.063 10.1007/BF02245592 10.1016/0014-2999(94)90033-7 10.1016/j.neulet.2003.10.040 10.1016/j.pneurobio.2007.05.001 10.1073/pnas.97.4.1856 10.1016/0091-3057(93)90525-X 10.1016/j.neuropharm.2006.05.005 10.1007/s12264-010-0323-7 10.1038/mp.2008.119 10.1007/s002130050037 10.1124/jpet.106.103143 |
ContentType | Journal Article |
Copyright | Copyright © 2014 Coelho, Alves, Canas, Valadas, Shmidt, Batalha, Ferreira, Ribeiro, Bader, Cunha, do Couto and Lopes. 2014 |
Copyright_xml | – notice: Copyright © 2014 Coelho, Alves, Canas, Valadas, Shmidt, Batalha, Ferreira, Ribeiro, Bader, Cunha, do Couto and Lopes. 2014 |
DBID | RCLKO NPM AAYXX CITATION 7X8 5PM DOA |
DOI | 10.3389/fpsyt.2014.00067 |
DatabaseName | RCAAP open access repository PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
DissertationSchool | Repositório da Universidade de Lisboa |
EISSN | 1664-0640 |
EndPage | 67 |
ExternalDocumentID | oai_doaj_org_article_6c5182f2b39245c2af7661390804b0d5 10_3389_fpsyt_2014_00067 24982640 10451_51216 |
Genre | Journal Article |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD ABIVO ACGFO ACGFS ACXDI ADBBV ADRAZ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV DIK EMOBN GROUPED_DOAJ GX1 HYE IAO IEA IHR IHW IPNFZ IPY KQ8 M48 M~E O5R O5S OK1 PGMZT RCLKO RIG RNS RPM NPM AAYXX AFPKN CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c4697-885eaef01eb498f1b6df23844f955f15b38119ffa1b18a0228344869a216b6963 |
IEDL.DBID | RPM |
ISSN | 1664-0640 |
IngestDate | Tue Oct 22 15:12:51 EDT 2024 Tue Sep 17 21:07:26 EDT 2024 Fri Oct 25 05:55:51 EDT 2024 Fri Aug 23 01:05:59 EDT 2024 Tue Oct 15 23:52:54 EDT 2024 Tue Oct 22 15:56:10 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | anxiety stress memory adenosine A2A receptors locomotion depression dopamine |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4697-885eaef01eb498f1b6df23844f955f15b38119ffa1b18a0228344869a216b6963 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Joana E. Coelho and Pedro Alves have contributed equally to this work. Edited by: Silvia Raquel Soares Ouakinin, University of Lisbon, Portugal This article was submitted to Affective Disorders and Psychosomatic Research, a section of the journal Frontiers in Psychiatry. Reviewed by: Chamindi Seneviratne, University of Maryland, USA; David Blum, INSERM, France |
ORCID | 0000-0002-3964-6197 0000-0002-9330-3507 0000-0002-2126-9485 0000-0001-6657-1111 0000-0001-8367-3005 0000-0002-3916-2598 0000-0001-5740-5904 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055866/ |
PMID | 24982640 |
PQID | 1542296482 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_6c5182f2b39245c2af7661390804b0d5 pubmedcentral_primary_oai_pubmedcentral_nih_gov_4055866 proquest_miscellaneous_1542296482 crossref_primary_10_3389_fpsyt_2014_00067 pubmed_primary_24982640 rcaap_revistas_10451_51216 |
PublicationCentury | 2000 |
PublicationDate | 2014-00-00 |
PublicationDateYYYYMMDD | 2014-01-01 |
PublicationDate_xml | – year: 2014 text: 2014-00-00 |
PublicationDecade | 2010 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Frontiers in psychiatry |
PublicationTitleAlternate | Front Psychiatry |
PublicationYear | 2014 |
Publisher | Frontiers Frontiers Media S.A |
Publisher_xml | – name: Frontiers – name: Frontiers Media S.A |
References | 18755516 - Trends Pharmacol Sci. 2008 Oct;29(10):493-8 15904709 - Behav Brain Res. 2005 Jun 3;161(1):45-59 16946186 - Am J Psychiatry. 2006 Sep;163(9):1594-602 12086672 - Cell. 2002 Jun 14;109(6):733-43 19639292 - Handb Exp Pharmacol. 2009;(193):471-534 18241242 - Brain Pathol. 2008 Apr;18(2):211-9 17572452 - Physiol Behav. 2007 Sep 10;92(1-2):210-7 21723327 - Behav Brain Res. 2011 Oct 31;224(2):376-86 20044138 - Neuropeptides. 2010 Jun;44(3):225-32 22298379 - Glia. 2012 May;60(5):702-16 19549518 - Eur J Pharmacol. 2009 Aug 15;616(1-3):128-33 20651815 - Neurosci Bull. 2010 Aug;26(4):327-37 16470403 - Psychopharmacology (Berl). 2006 Apr;185(2):160-8 19523988 - Behav Brain Res. 2009 Dec 1;204(1):162-8 16824773 - Neurobiol Learn Mem. 2007 Jan;87(1):42-56 22371048 - Mol Psychiatry. 2013 Mar;18(3):320-31 11969069 - Ontogenez. 2002 Mar-Apr;33(2):107-10 17035531 - J Neurosci. 2006 Oct 11;26(41):10472-9 15266352 - Neuropsychopharmacology. 2004 Nov;29(11):2007-17 1876670 - Psychopharmacology (Berl). 1991;104(2):255-9 10677546 - Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1856-60 8539342 - Psychopharmacology (Berl). 1995 Sep;121(1):66-72 10601453 - J Neurophysiol. 1999 Dec;82(6):3196-203 16099045 - Neurosci Biobehav Rev. 2006;30(2):215-38 19141075 - J Neurochem. 2009 Mar;108(5):1208-19 17408759 - Trends Neurosci. 2007 May;30(5):194-202 15148138 - Arch Neurol. 2004 May;61(5):641-4 8640355 - Br J Pharmacol. 1995 Oct;116(3):2127-33 15893822 - Neurosci Biobehav Rev. 2005;29(4-5):547-69 17646043 - Prog Neurobiol. 2007 Dec;83(5):277-92 12008002 - Trends Pharmacol Sci. 2002 May;23(5):238-45 10962152 - Neurosci Lett. 2000 Sep 8;291(1):54-8 9246450 - Cold Spring Harb Symp Quant Biol. 1996;61:219-24 19325164 - Schizophr Bull. 2009 May;35(3):549-62 9347617 - Trends Neurosci. 1997 Oct;20(10):482-7 20730044 - Open Neurosci J. 2010 Jan 1;4:93-101 16123762 - Neuropsychopharmacology. 2006 Mar;31(3):525-34 23820821 - Biol Psychiatry. 2014 Jun 1;75(11):855-63 9262401 - Nature. 1997 Aug 14;388(6643):674-8 12600700 - Eur J Pharmacol. 2003 Feb 28;463(1-3):3-33 19652957 - Psychopharmacology (Berl). 2009 Oct;206(2):313-24 11378179 - Neurosci Biobehav Rev. 2001 May;25(3):235-60 18982002 - Mol Psychiatry. 2009 Aug;14 (8):764-73, 739 22981666 - Eur J Pharmacol. 2012 Nov 15;695(1-3):71-5 16043128 - Biol Psychiatry. 2005 Dec 1;58(11):843-53 20211657 - Behav Brain Res. 2010 Aug 25;211(2):148-55 11734617 - Pharmacol Rev. 2001 Dec;53(4):527-52 18289757 - Prog Neuropsychopharmacol Biol Psychiatry. 2008 May 15;32(4):994-9 10663430 - Psychopharmacology (Berl). 2000 Feb;148(2):153-63 16292317 - Neuropsychopharmacology. 2006 Sep;31(9):1928-37 16123743 - Neuropsychopharmacology. 2006 May;31(5):978-87 11432985 - J Neurochem. 2001 Jul;78(1):183-98 15659214 - J Neurochem. 2005 Feb;92 (3):433-41 15922073 - Behav Brain Res. 2005 Jul 1;162(1):127-34 15893632 - Neuroscience. 2005;133(1):79-83 17329439 - J Neurosci. 2007 Feb 28;27(9):2410-5 8101381 - Pharmacol Biochem Behav. 1993 Jul;45(3):685-90 21615561 - Eur J Neurosci. 2011 Jul;34(1):12-21 1480347 - Neurosci Biobehav Rev. 1992 Winter;16(4):507-17 12700682 - Neuropsychopharmacology. 2003 Jul;28(7):1281-91 15774265 - Neurosci Lett. 2005 Apr 18;378(2):98-101 14663017 - Neurology. 2003 Dec 9;61(11 Suppl 6):S82-7 19457367 - Neuroimage. 2009 May 15;46(1):327-37 18536706 - Neuropsychopharmacology. 2009 Mar;34(4):844-56 12825092 - Neuropsychopharmacology. 2003 Sep;28(9):1694-702 559941 - Nature. 1977 Apr 21;266(5604):730-2 19513088 - Nat Rev Neurosci. 2009 Jul;10(7):519-29 17328889 - Eur J Pharmacol. 2007 May 7;562(1-2):72-6 20726873 - Epilepsia. 2010 Sep;51(9):1721-8 12044450 - Neuroscience. 2002;112(2):319-29 17986650 - J Pharmacol Exp Ther. 2008 Feb;324(2):714-24 16481441 - J Neurosci. 2006 Feb 15;26(7):2080-7 9295170 - J Neural Transm (Vienna). 1997;104(4-5):341-62 19411368 - Am J Psychiatry. 2009 Jun;166(6):702-10 19955361 - J Neurosci. 2009 Dec 2;29(48):15100-3 19007903 - Prostaglandins Other Lipid Mediat. 2009 Apr;88(3-4):68-72 16226742 - Eur J Pharmacol. 2005 Oct 31;523(1-3):71-8 23638679 - Br J Pharmacol. 2013 Aug;169(7):1600-11 21076988 - J Neural Transm (Vienna). 2010 Dec;117(12):1359-69 7813561 - Eur J Pharmacol. 1994 Sep 1;262(1-2):107-11 16803860 - J Pharmacol Exp Ther. 2006 Oct;319(1):254-9 16793068 - Neuropharmacology. 2006 Sep;51(3):631-40 14729225 - Neurosci Lett. 2004 Jan 23;355(1-2):21-4 12576292 - Prog Neurobiol. 2002 Dec;68(6):377-92 14978196 - J Pharmacol Exp Ther. 2004 Jun;309(3):936-50 Ledent (B47) 1997; 388 Kaster (B44) 2004; 355 Schiffmann (B56) 2007; 83 Braun (B51) 1997; 104 Dassesse (B83) 2001; 78 Muscat (B25) 1992; 16 Batalha (B32) 2013; 18 Short (B78) 2006; 31 Rodrigues (B85) 2005; 92 Svenningsson (B84) 2000; 97 Karcz-Kubicha (B48) 2003; 28 Papp (B39) 1991; 104 Lopes (B73) 2002; 112 Collins (B50) 2010; 211 Millan (B57) 2004; 309 Albasanz (B8) 2008; 18 Lopes (B72) 1999; 82 Brown (B61) 2009; 34 Brooks (B28) 2009; 10 Hurley (B9) 2000; 291 Fredholm (B11) 2001; 53 Yu (B63) 2009; 29 Kuzmin (B66) 2006; 31 Li (B67) 2011; 224 Rygula (B26) 2005; 162 Porsolt (B35) 1977; 266 Rétey (B2) 2006; 26 Gomes (B69) 2009; 108 Fuxe (B24) 2007; 92 Costenla (B77) 2011; 34 Girault (B13) 2004; 61 Elmenhorst (B3) 2007; 27 Urigüen (B10) 2009; 206 Yan (B27) 2010; 26 D’Aquila (B80) 1994; 262 Ciruela (B74) 2006; 26 Giménez-Llort (B53) 2007; 87 Korchounov (B21) 2010; 117 Ramos (B59) 2008; 29 El Yacoubi (B43) 2003; 61 Cryan (B42) 2005; 29 Prut (B52) 2003; 463 Howes (B16) 2009; 35 Bessa (B40) 2009; 14 Garção (B68) 2013; 169 Katsuura (B65) 2010; 44 Keedwell (B18) 2005; 58 Jain (B49) 1995; 116 Simões do Couto (B41) 2012; 695 Mayford (B31) 1996; 61 Bekris (B34) 2005; 161 Hirano (B81) 2007; 562 Lam (B6) 2005; 378 Detke (B37) 1995; 121 Ribeiro (B12) 2002; 68 Cryan (B36) 2002; 23 Soria (B62) 2006; 31 Matos (B76) 2012; 60 Meyer (B22) 2006; 163 Rebola (B75) 2005; 133 Strekalova (B33) 2004; 29 Listos (B71) 2005; 523 Castañà (B46) 2006; 51 Lobato (B45) 2008; 32 Popova (B30) 2002; 33 Yao (B82) 2002; 109 Alsene (B7) 2003; 28 Sadock (B20) 2009 Wei (B54) 2013; 75 Castagne (B38) 2009; 616 Wacker (B19) 2009; 46 Pizzagalli (B17) 2009; 166 Bilbao (B60) 2006; 185 Boison (B4) 2010; 4 Ferrà (B23) 1997; 20 Li (B86) 2006; 319 McAuley (B58) 2009; 204 Pierce (B15) 2006; 30 Choleris (B29) 2001; 25 El Yacoubi (B55) 2000; 148 Zhao (B70) 2009; 88 Sebastião (B1) 2009 Jutkiewicz (B64) 2008; 324 Bjorklund (B14) 2007; 30 Simon (B79) 1993; 45 Van Dycke (B5) 2010; 51 |
References_xml | – volume: 163 start-page: 1594 issue: 9 year: 2006 ident: B22 article-title: Elevated putamen D(2) receptor binding potential in major depression with motor retardation: an [11C]raclopride positron emission tomography study publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.163.9.1594 contributor: fullname: Meyer – volume: 34 start-page: 844 issue: 4 year: 2009 ident: B61 article-title: A differential role for the adenosine A2A receptor in opiate reinforcement vs opiate-seeking behavior publication-title: Neuropsychopharmacology doi: 10.1038/npp.2008.72 contributor: fullname: Brown – volume: 117 start-page: 1359 issue: 12 year: 2010 ident: B21 article-title: Postsynaptic nigrostriatal dopamine receptors and their role in movement regulation publication-title: J Neural Transm doi: 10.1007/s00702-010-0454-z contributor: fullname: Korchounov – volume: 169 start-page: 1600 issue: 7 year: 2013 ident: B68 article-title: Functional interaction between pre-synaptic α6β2-containing nicotinic and adenosine A2A receptors in the control of dopamine release in the rat striatum publication-title: Br J Pharmacol doi: 10.1111/bph.12234 contributor: fullname: Garção – volume: 10 start-page: 519 issue: 7 year: 2009 ident: B28 article-title: Tests to assess motor phenotype in mice: a user’s guide publication-title: Nat Rev Neurosci doi: 10.1038/nrn2652 contributor: fullname: Brooks – volume: 26 start-page: 10472 issue: 41 year: 2006 ident: B2 article-title: Adenosinergic mechanisms contribute to individual differences in sleep deprivation-induced changes in neurobehavioral function and brain rhythmic activity publication-title: J Neurosci doi: 10.1523/JNEUROSCI.1538-06.2006 contributor: fullname: Rétey – volume: 224 start-page: 376 issue: 2 year: 2011 ident: B67 article-title: Behavioural and neuronal activation after microinjections of AMPA and NMDA into the perifornical lateral hypothalamus in rats publication-title: Behav Brain Res doi: 10.1016/j.bbr.2011.06.021 contributor: fullname: Li – volume: 33 start-page: 107 year: 2002 ident: B30 article-title: In vitro development of murine embryos using different types of microinjections publication-title: Ontogenez doi: 10.1023/A:1014912128311 contributor: fullname: Popova – volume: 58 start-page: 843 issue: 11 year: 2005 ident: B18 article-title: The neural correlates of anhedonia in major depressive disorder publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2005.05.019 contributor: fullname: Keedwell – volume: 75 start-page: 855 issue: 11 year: 2013 ident: B54 article-title: Regulation of fear responses by striatal and extrastriatal adenosine A2A receptors in forebrain publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2013.05.003 contributor: fullname: Wei – volume: 82 start-page: 196 issue: 3 year: 1999 ident: B72 article-title: Cross talk between A(1) and A(2A) adenosine receptors in the hippocampus and cortex of young adult and old rats publication-title: J Neurophysiol contributor: fullname: Lopes – volume: 161 start-page: 45 issue: 1 year: 2005 ident: B34 article-title: Behavioural and neurochemical effects induced by chronic mild stress applied to two different rat strains publication-title: Behav Brain Res doi: 10.1016/j.bbr.2005.01.005 contributor: fullname: Bekris – volume: 78 start-page: 183 issue: 1 year: 2001 ident: B83 article-title: Functional striatal hypodopaminergic activity in mice lacking adenosine A(2A) receptors publication-title: J Neurochem doi: 10.1046/j.1471-4159.2001.00389.x contributor: fullname: Dassesse – volume: 388 start-page: 674 issue: 6643 year: 1997 ident: B47 article-title: Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor publication-title: Nature doi: 10.1038/41771 contributor: fullname: Ledent – volume: 204 start-page: 162 issue: 1 year: 2009 ident: B58 article-title: Wistar-Kyoto rats as an animal model of anxiety vulnerability: support for a hypervigilance hypothesis publication-title: Behav Brain Res doi: 10.1016/j.bbr.2009.05.036 contributor: fullname: McAuley – volume: 88 start-page: 68 issue: 3–4 year: 2009 ident: B70 article-title: Central prostaglandin D(2) exhibits anxiolytic-like activity via the DP(1) receptor in mice publication-title: Prostaglandins Other Lipid Mediat doi: 10.1016/j.prostaglandins.2008.10.001 contributor: fullname: Zhao – volume: 104 start-page: 341 issue: 4–5 year: 1997 ident: B51 article-title: Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications publication-title: J Neural Transm doi: 10.1007/BF01277656 contributor: fullname: Braun – volume: 92 start-page: 433 issue: 3 year: 2005 ident: B85 article-title: Co-localization and functional interaction between adenosine A(2A) and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum publication-title: J Neurochem doi: 10.1111/j.1471-4159.2004.02887.x contributor: fullname: Rodrigues – start-page: 471 volume-title: Handb Exp Pharmacol year: 2009 ident: B1 article-title: Adenosine receptors and the central nervous system contributor: fullname: Sebastião – volume: 23 start-page: 238 issue: 5 year: 2002 ident: B36 article-title: Assessing antidepressant activity in rodents: recent developments and future needs publication-title: Trends Pharmacol Sci doi: 10.1016/S0165-6147(02)02017-5 contributor: fullname: Cryan – volume: 116 start-page: 2127 issue: 3 year: 1995 ident: B49 article-title: Anxiolytic activity of adenosine receptor activation in mice publication-title: Br J Pharmacol doi: 10.1111/j.1476-5381.1995.tb16421.x contributor: fullname: Jain – volume: 523 start-page: 71 issue: 1–3 year: 2005 ident: B71 article-title: Influence of adenosine receptor agonists on benzodiazepine withdrawal signs in mice publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2005.07.025 contributor: fullname: Listos – volume: 18 start-page: 320 year: 2013 ident: B32 article-title: Adenosine A2A receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation publication-title: Mol Psychiatry doi: 10.1038/mp.2012.8 contributor: fullname: Batalha – volume: 35 start-page: 549 issue: 3 year: 2009 ident: B16 article-title: The dopamine hypothesis of schizophrenia: version III – the final common pathway publication-title: Schizophr Bull doi: 10.1093/schbul/sbp006 contributor: fullname: Howes – volume: 31 start-page: 1928 issue: 9 year: 2006 ident: B66 article-title: Big dynorphin, a prodynorphin-derived peptide produces NMDA receptor-mediated effects on memory, anxiolytic-like and locomotor behavior in mice publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300959 contributor: fullname: Kuzmin – volume: 30 start-page: 194 issue: 5 year: 2007 ident: B14 article-title: Dopamine neuron systems in the brain: an update publication-title: Trends Neurosci doi: 10.1016/j.tins.2007.03.006 contributor: fullname: Bjorklund – volume: 51 start-page: 1721 issue: 9 year: 2010 ident: B5 article-title: Continuous local intrahippocampal delivery of adenosine reduces seizure frequency in rats with spontaneous seizures publication-title: Epilepsia doi: 10.1111/j.1528-1167.2010.02700.x contributor: fullname: Van Dycke – volume: 31 start-page: 978 issue: 5 year: 2006 ident: B62 article-title: The lack of A2A adenosine receptors diminishes the reinforcing efficacy of cocaine publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300876 contributor: fullname: Soria – volume: 25 start-page: 235 issue: 3 year: 2001 ident: B29 article-title: A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field publication-title: Neurosci Biobehav Rev doi: 10.1016/S0149-7634(01)00011-2 contributor: fullname: Choleris – volume: 16 start-page: 507 issue: 4 year: 1992 ident: B25 article-title: Suppression of sucrose drinking by chronic mild unpredictable stress: a methodological analysis publication-title: Neurosci Biobehav Rev doi: 10.1016/S0149-7634(05)80192-7 contributor: fullname: Muscat – volume: 87 start-page: 42 issue: 1 year: 2007 ident: B53 article-title: Working memory deficits in transgenic rats overexpressing human adenosine A2A receptors in the brain publication-title: Neurobiol Learn Mem doi: 10.1016/j.nlm.2006.05.004 contributor: fullname: Giménez-Llort – start-page: 1875 volume-title: Kaplan and Sadock’s Comprehensive Textbook of Psychiatry year: 2009 ident: B20 contributor: fullname: Sadock – volume: 20 start-page: 482 issue: 10 year: 1997 ident: B23 article-title: Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia publication-title: Trends Neurosci doi: 10.1016/S0166-2236(97)01096-5 contributor: fullname: Ferrà – volume: 29 start-page: 2007 issue: 11 year: 2004 ident: B33 article-title: Stress-induced anhedonia in mice is associated with deficits in forced swimming and exploration publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300532 contributor: fullname: Strekalova – volume: 28 start-page: 1281 issue: 7 year: 2003 ident: B48 article-title: Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300167 contributor: fullname: Karcz-Kubicha – volume: 463 start-page: 3 issue: 1–3 year: 2003 ident: B52 article-title: The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review publication-title: Eur J Pharmacol doi: 10.1016/S0014-2999(03)01272-X contributor: fullname: Prut – volume: 378 start-page: 98 issue: 2 year: 2005 ident: B6 article-title: Association study of A2a adenosine receptor genetic polymorphism in panic disorder publication-title: Neurosci Lett doi: 10.1016/j.neulet.2004.12.012 contributor: fullname: Lam – volume: 616 start-page: 128 issue: 1–3 year: 2009 ident: B38 article-title: Use of latency to immobility improves detection of antidepressant-like activity in the behavioral despair test in the mouse publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2009.06.018 contributor: fullname: Castagne – volume: 31 start-page: 525 issue: 3 year: 2006 ident: B78 article-title: Receptor crosstalk: characterization of mice deficient in dopamine D1 and adenosine A2A receptors publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300852 contributor: fullname: Short – volume: 4 start-page: 93 year: 2010 ident: B4 article-title: Adenosine dysfunction and adenosine kinase in epileptogenesis publication-title: Open Neurosci J doi: 10.2174/1874082001004020093 contributor: fullname: Boison – volume: 32 start-page: 994 issue: 4 year: 2008 ident: B45 article-title: Involvement of the adenosine A1 and A2A receptors in the antidepressant-like effect of zinc in the forced swimming test publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2008.01.012 contributor: fullname: Lobato – volume: 18 start-page: 211 issue: 2 year: 2008 ident: B8 article-title: Up-regulation of adenosine receptors in the frontal cortex in Alzheimer’s disease publication-title: Brain Pathol doi: 10.1111/j.1750-3639.2007.00112.x contributor: fullname: Albasanz – volume: 291 start-page: 54 issue: 1 year: 2000 ident: B9 article-title: Adenosine A(2A) receptor mRNA expression in Parkinson’s disease publication-title: Neurosci Lett doi: 10.1016/S0304-3940(00)01371-9 contributor: fullname: Hurley – volume: 104 start-page: 255 issue: 2 year: 1991 ident: B39 article-title: An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress publication-title: Psychopharmacology doi: 10.1007/BF02244188 contributor: fullname: Papp – volume: 695 start-page: 71 issue: 1–3 year: 2012 ident: B41 article-title: Escitalopram improves memory deficits induced by maternal separation in the rat publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2012.08.020 contributor: fullname: Simões do Couto – volume: 166 start-page: 702 issue: 6 year: 2009 ident: B17 article-title: Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.2008.08081201 contributor: fullname: Pizzagalli – volume: 61 start-page: S82 issue: 11 Suppl 6 year: 2003 ident: B43 article-title: Adenosine A2A receptors and depression publication-title: Neurology doi: 10.1212/01.WNL.0000095220.87550.F6 contributor: fullname: El Yacoubi – volume: 29 start-page: 493 issue: 10 year: 2008 ident: B59 article-title: Animal models of anxiety: do I need multiple tests? publication-title: Trends Pharmacol Sci doi: 10.1016/j.tips.2008.07.005 contributor: fullname: Ramos – volume: 44 start-page: 225 issue: 3 year: 2010 ident: B65 article-title: Modulation of feeding and locomotion through mu and delta opioid receptor signaling in the nucleus accumbens publication-title: Neuropeptides doi: 10.1016/j.npep.2009.12.002 contributor: fullname: Katsuura – volume: 133 start-page: 79 year: 2005 ident: B75 article-title: Adenosine A1 and A2A receptors are co-expressed in pyramidal neurons and co-localized in glutamatergic nerve terminals of the rat hippocampus publication-title: Neuroscience doi: 10.1016/j.neuroscience.2005.01.054 contributor: fullname: Rebola – volume: 29 start-page: 15100 issue: 48 year: 2009 ident: B63 article-title: Genetic deletion of A2A adenosine receptors in the striatum selectively impairs habit formation publication-title: J Neurosci doi: 10.1523/JNEUROSCI.4215-09.2009 contributor: fullname: Yu – volume: 109 start-page: 733 issue: 6 year: 2002 ident: B82 article-title: beta gamma Dimers mediate synergy of dopamine D2 and adenosine A2 receptor-stimulated PKA signaling and regulate ethanol consumption publication-title: Cell doi: 10.1016/S0092-8674(02)00763-8 contributor: fullname: Yao – volume: 309 start-page: 936 issue: 3 year: 2004 ident: B57 article-title: S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: III. Actions in models of potential antidepressive and anxiolytic activity in comparison with ropinirole publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.103.062463 contributor: fullname: Millan – volume: 108 start-page: 1208 issue: 5 year: 2009 ident: B69 article-title: GDNF control of the glutamatergic cortico-striatal pathway requires tonic activation of adenosine A receptors publication-title: J Neurochem doi: 10.1111/j.1471-4159.2009.05876.x contributor: fullname: Gomes – volume: 61 start-page: 641 issue: 5 year: 2004 ident: B13 article-title: The neurobiology of dopamine signaling publication-title: Arch Neurol doi: 10.1001/archneur.61.5.641 contributor: fullname: Girault – volume: 27 start-page: 2410 issue: 9 year: 2007 ident: B3 article-title: Sleep deprivation increases A1 adenosine receptor binding in the human brain: a positron emission tomography study publication-title: J Neurosci doi: 10.1523/JNEUROSCI.5066-06.2007 contributor: fullname: Elmenhorst – volume: 34 start-page: 12 year: 2011 ident: B77 article-title: Enhanced role of adenosine A(2A) receptors in the modulation of LTP in the rat hippocampus upon ageing publication-title: Eur J Neurosci doi: 10.1111/j.1460-9568.2011.07719.x contributor: fullname: Costenla – volume: 30 start-page: 215 issue: 2 year: 2006 ident: B15 article-title: The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse? publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2005.04.016 contributor: fullname: Pierce – volume: 266 start-page: 730 issue: 5604 year: 1977 ident: B35 article-title: Depression: a new animal model sensitive to antidepressant treatments publication-title: Nature doi: 10.1038/266730a0 contributor: fullname: Porsolt – volume: 185 start-page: 160 issue: 2 year: 2006 ident: B60 article-title: Absence of quasi-morphine withdrawal syndrome in adenosine A2A receptor knockout mice publication-title: Psychopharmacology doi: 10.1007/s00213-005-0284-0 contributor: fullname: Bilbao – volume: 112 start-page: 319 year: 2002 ident: B73 article-title: Adenosine A(2A) receptor facilitation of hippocampal synaptic transmission is dependent on tonic A(1) receptor inhibition publication-title: Neuroscience doi: 10.1016/S0306-4522(02)00080-5 contributor: fullname: Lopes – volume: 26 start-page: 2080 year: 2006 ident: B74 article-title: Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers publication-title: J Neurosci doi: 10.1523/JNEUROSCI.3574-05.2006 contributor: fullname: Ciruela – volume: 28 start-page: 1694 issue: 9 year: 2003 ident: B7 article-title: Association between A2a receptor gene polymorphisms and caffeine-induced anxiety publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300232 contributor: fullname: Alsene – volume: 324 start-page: 714 issue: 2 year: 2008 ident: B64 article-title: The delta-opioid receptor agonist SNC80 [(+)-4-[alpha(R)-alpha-[(2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl]-(3-met hoxybenzyl)-N,N-diethylbenzamide] synergistically enhances the locomotor-activating effects of some psychomotor stimulants, but not direct dopamine agonists, in rats publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.107.123844 contributor: fullname: Jutkiewicz – volume: 60 start-page: 702 issue: 5 year: 2012 ident: B76 article-title: Adenosine A2A receptors modulate glutamate uptake in cultured astrocytes and gliosomes publication-title: Glia doi: 10.1002/glia.22290 contributor: fullname: Matos – volume: 92 start-page: 210 issue: 1–2 year: 2007 ident: B24 article-title: Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function publication-title: Physiol Behav doi: 10.1016/j.physbeh.2007.05.034 contributor: fullname: Fuxe – volume: 162 start-page: 127 issue: 1 year: 2005 ident: B26 article-title: Anhedonia and motivational deficits in rats: impact of chronic social stress publication-title: Behav Brain Res doi: 10.1016/j.bbr.2005.03.009 contributor: fullname: Rygula – volume: 29 start-page: 547 issue: 4–5 year: 2005 ident: B42 article-title: Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2005.03.008 contributor: fullname: Cryan – volume: 68 start-page: 377 issue: 6 year: 2002 ident: B12 article-title: Adenosine receptors in the nervous system: pathophysiological implications publication-title: Prog Neurobiol doi: 10.1016/S0301-0082(02)00155-7 contributor: fullname: Ribeiro – volume: 46 start-page: 327 issue: 1 year: 2009 ident: B19 article-title: The role of the nucleus accumbens and rostral anterior cingulate cortex in anhedonia: integration of resting EEG, fMRI, and volumetric techniques publication-title: Neuroimage doi: 10.1016/j.neuroimage.2009.01.058 contributor: fullname: Wacker – volume: 206 start-page: 313 issue: 2 year: 2009 ident: B10 article-title: Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment publication-title: Psychopharmacology doi: 10.1007/s00213-009-1608-2 contributor: fullname: Urigüen – volume: 211 start-page: 148 issue: 2 year: 2010 ident: B50 article-title: Interactions between adenosine and dopamine receptor antagonists with different selectivity profiles: effects on locomotor activity publication-title: Behav Brain Res doi: 10.1016/j.bbr.2010.03.003 contributor: fullname: Collins – volume: 61 start-page: 219 year: 1996 ident: B31 article-title: CaMKII function in the nervous system explored from a genetic perspective publication-title: Cold Spring Harb Symp Quant Biol doi: 10.1101/SQB.1996.061.01.024 contributor: fullname: Mayford – volume: 562 start-page: 72 issue: 1–2 year: 2007 ident: B81 article-title: Involvement of dopamine D1 receptors and alpha1-adrenoceptors in the antidepressant-like effect of chlorpheniramine in the mouse tail suspension test publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2007.01.063 contributor: fullname: Hirano – volume: 121 start-page: 66 issue: 1 year: 1995 ident: B37 article-title: Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants publication-title: Psychopharmacology doi: 10.1007/BF02245592 contributor: fullname: Detke – volume: 262 start-page: 107 issue: 1–2 year: 1994 ident: B80 article-title: Antidepressant-like effect of selective dopamine D1 receptor agonists in the behavioural despair animal model of depression publication-title: Eur J Pharmacol doi: 10.1016/0014-2999(94)90033-7 contributor: fullname: D’Aquila – volume: 355 start-page: 21 issue: 1–2 year: 2004 ident: B44 article-title: Adenosine administration produces an antidepressant-like effect in mice: evidence for the involvement of A1 and A2A receptors publication-title: Neurosci Lett doi: 10.1016/j.neulet.2003.10.040 contributor: fullname: Kaster – volume: 83 start-page: 277 issue: 5 year: 2007 ident: B56 article-title: Adenosine A2A receptors and basal ganglia physiology publication-title: Prog Neurobiol doi: 10.1016/j.pneurobio.2007.05.001 contributor: fullname: Schiffmann – volume: 97 start-page: 1856 issue: 4 year: 2000 ident: B84 article-title: Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.97.4.1856 contributor: fullname: Svenningsson – volume: 45 start-page: 685 issue: 3 year: 1993 ident: B79 article-title: Anxiogenic-like effects induced by stimulation of dopamine receptors publication-title: Pharmacol Biochem Behav doi: 10.1016/0091-3057(93)90525-X contributor: fullname: Simon – volume: 51 start-page: 631 issue: 3 year: 2006 ident: B46 article-title: Attenuation of nicotine-induced rewarding effects in A2A knockout mice publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2006.05.005 contributor: fullname: Castañà – volume: 53 start-page: 527 issue: 4 year: 2001 ident: B11 article-title: International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors publication-title: Pharmacol Rev contributor: fullname: Fredholm – volume: 26 start-page: 327 issue: 4 year: 2010 ident: B27 article-title: Behavioral animal models of depression publication-title: Neurosci Bull doi: 10.1007/s12264-010-0323-7 contributor: fullname: Yan – volume: 14 start-page: 764 issue: 8 year: 2009 ident: B40 article-title: The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling publication-title: Mol Psychiatry doi: 10.1038/mp.2008.119 contributor: fullname: Bessa – volume: 148 start-page: 153 issue: 2 year: 2000 ident: B55 article-title: The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A(2A) adenosine receptor antagonists publication-title: Psychopharmacology doi: 10.1007/s002130050037 contributor: fullname: El Yacoubi – volume: 319 start-page: 254 issue: 1 year: 2006 ident: B86 article-title: Metabotropic glutamate 5 receptor antagonism is associated with antidepressant-like effects in mice publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.106.103143 contributor: fullname: Li |
SSID | ssj0000399365 |
Score | 2.342566 |
Snippet | Copyright: © 2014 Coelho, Alves, Canas, Valadas, Shmidt, Batalha, Ferreira, Ribeiro, Bader, Cunha, do Couto and Lopes. This is an open-access article... Adenosine A2A receptors (A2AR) are a sub-type of receptors enriched in basal ganglia, activated by the neuromodulator adenosine, which interact with dopamine... Adenosine A 2A receptors (A 2A R) are a sub-type of receptors enriched in basal ganglia, activated by the neuromodulator adenosine, which interact with... |
SourceID | doaj pubmedcentral proquest crossref pubmed rcaap |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 67 |
SubjectTerms | Adenosine A2A receptors Alzheimer's disease Anxiety Depression Dopamine Locomotion Memory Psychiatry Stress |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3BatwwEBUhveRSWtq0TpqiQi-BmEiKJFu5bUtDKLS5JJCbqrElmot2ySaQ_n1nJGezSwu99OCLbZA9z_J7Iw1vGPsYhOuiHWPb6eha3QfRBrDQQhAnA2iNIpuWBr59t-dX-uu1uV5r9UU1YdUeuAbu2A4GJXBSgESuzaBC6pBSMFPvhQYxVvdS4daSqfIPJt61pu5LYhbmjtNi-YtqJyW5ZYvSVv6Jh4pd_9805p-lks9uhxAWaxx09oI9n8Qjn9WHfsm2Yn7Fflzg1xgfpoLWzOeJh5EswFE_8pmacfynxQU11eE3mSPgy1M-VXFwvH1VCpuPOBLbvLb14SGPeDxQRedrdnX25fLzeTv1TWgHTHaRdHoTQ0xCRtCuTxLsmJCZtU7OmCQNIEtLl1KQIBEcMsDBJM26oKQFizNyl23neY5vGVcwDGksu75RO6GgiwnI4_1EqwQQGnb4GEW_qPYYHtMKirgvEfcUcV8i3rBPFObVfWRsXU4g3H6C2_8L7oZ9eATJ40Sg3Y2Q4_x-6VELKtpD7lXD3lTQVkNhjolplBYN6zbg3HiWzSv55mcx20ZBa3prG7ZXgPdUfI26HccjZx6Peknavf_xZvtsh2JVl3fese272_t4gILnDt6Xb_s3oiT80Q priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3di9QwEB_07sUXUfzqeUoEX4SrNtkkbQWR-nEc4geIC_cWkjY5DyTd2-7B3n_vTNo9XdwHX9vQhJlM5jeZ6W8AntuiLr3ufF5KX-eyskVunXa5s8WsdVIiyKargS9f9clcfjpVp39-j54EOOwM7aif1Hz56-X64uotGvwbijjR374Ki-GKyiI5EWHj6XsT9gXRclEh3wT207lMvjj1luRay5xSWGPecudHtvxUovPfhUH_LaXcX7bWLv7yUcd34PYELlkz7oa7cMPHe2C_4W7166ngNbI-sKYjinDEl6wRDUPk6BfUdIedR_bdrobXbOQ0HhgO_7AplY1H7HPf9mPbnyNmY8eauKaSz_swP_744_1JPjVWyFuMhtErVcpbHwrunayrwJ3uArpuKUOtVODKoRvndQiWO47aI4YcjOJ0bQXXTqPJPoC92Ef_CJhwbRu6lBb2si6EK31wRAI_kyI4ZzN4sRGjWYz8GQbjDhK5SSI3JHKTRJ7BO5Lz9Thivk4P-uWZmQzJ6FZhSBSEQ2AnVStsKBFizGpEvtIVncrg2UZLBi2F0h82-v5yMAgWBSWZK5HBw1Fr11NhEIpxliwyKLf0ubWW7Tfx_Gdi40bEqyqtMzhImjdUnY3AHucj6h6DgIrrg_9Y1GO4RaIYr3cOYW-1vPRPEPCs3NO0j38DnVD8sA priority: 102 providerName: Scholars Portal |
Title | Overexpression of Adenosine A2A receptors in rats: effects on depression, locomotion, and anxiety |
URI | http://hdl.handle.net/10451/51216 https://www.ncbi.nlm.nih.gov/pubmed/24982640 https://search.proquest.com/docview/1542296482 https://pubmed.ncbi.nlm.nih.gov/PMC4055866 https://doaj.org/article/6c5182f2b39245c2af7661390804b0d5 |
Volume | 5 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELXacuGCQHylQGUkLkhNN87aTswtFKoKsYAQlXqzbMcuK1En2t1K5d8z4yTVruDEJYfEysfM2PPGfnkm5I0pVOVl6_OKe5Xz2hS5sdLm1hRzZzkHkI1TA4sv8vyCf7oUl3tETP_CJNK-s8uT-Ov6JC5_Jm5lf-1mE09s9m1xCiBD1FLO9sk-BOhWiZ6GX0y5UgxLklCAqVno17-RNslQKBtGZxQA5gpwNc54bGWjJNr_L6T5N2Hy3soZ029lorOH5MEIIWkzvOojsufjY2K-Qkz625HWGmkXaNOiEDigSNqUDQV86HvcWocuI_1uNut3dFAuXlNo_mEixMZj-rlz3bC5zzE1saVNvEVi5xNycfbxx-l5Pm6fkDuoeSH31MIbHwrmLXxtYFa2ARI050EJEZiwkKyZCsEwy8BHqIMDtZpUpmTSSuiYT8lB7KJ_TmhpnQttWvz1XBWlrXywKPU-52Ww1mTk7WRG3Q8qGRqqC7S-TtbXaH2drJ-R92jnu3aob51OdKsrPXpZSyeg8AmlBfjGhStNqABIzBXgW26LVmTk9eQlDf0BFzlM9N3NWgMkLHEpuS4z8mzw2t2jJq9npNrx58677F6BEEya22PIZeQweV4jBxvgOzwPBXo0wCYmD__7ti_IfTTQMLXzkhxsVjf-FYCdjT1KkwRwXPD6KAX6Hx-G_9c |
link.rule.ids | 230,315,730,783,787,867,888,2109,4033,24332,27937,27938,27939,53806,53808 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFL0q7QI2PMSjKS8jsUFqZpKM7UzYhUI1wExBqEXdWbZjwwjqRPOQCl_PtZNUM8AGtnGUh8917rn2yTHAc5kUueGViXNqipiOZRJLxVWsZDLSilIk2X5qYHbCJ2f03Tk73wHW_wsTRPtazQfu-8XAzb8GbWVzoYe9Tmz4cXaEJIONOR9egz0crwnfKNLDB9gnXc7aRUkswYqhbZY_vHAy9VbZ-H32FsC0QGbt5zw28lGw7f8b1_xTMrm30FI2G7no-BZ87t-ilaB8G6xXaqB__mbw-M-veRtuduyUlG3zHdgx7i7IDxju5rJTzDpSW1JW3mMcCSops5Ig9TSN37WHzB35JFfLl6Q1RV4SPP11r7V1h2Ra67rdN-iQSFeR0l16zeg9ODt-c3o0ibudGWKN5TSmtTEz0tgkNQq70aaKVxZzP6W2YMymTCEPSAtrZapShN9b7GAZyAuZpVxxHPP3YdfVzuwDyZTWtgrryoYWSaZyY5V3kR_RzColI3jR4yOa1oBDYOHiYRUBVuFhFQHWCF55AK_O89bZ4UC9-CK6nhVcM6ypbKaQGVKmM2lz5CijAqkzVUnFInjWwy9wqPn1E-lMvV4KZJuZX6UeZxE8aMPh6lZ9OEWQbwXK1rNstyDswc67gzmCgxBSwsu7sTLA-3nvH4GMLOUH_33Zp3B9cjqbiunbk_cP4YbvrHYG6RHsrhZr8xg51Uo9CSPoFz6ZIBE |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaglRAXHuLRlJeRuCA1u0nWdhJuoWVVoC0VolLFxbIdG1ZQJ9qHVPj1zDhJtQucek2sOPbM2N_Yn74h5JVKytyK2sY5s2XMCpXESgsda5VMjGYMQDYeDRyfiMMz9uGcn6-V-gqkfaNnI__zYuRn3wO3sr0w44EnNj493geQwQshxm3txjfJNsRsUqwl6mERxo1X8O5iEtKwcuzaxS8kT6Yolw1rNMoAsxLQNZ57rO1JQbr_f3jzX9rk9two1a7tR9O75Oswko6G8mO0WuqR-f2XyOO1hnqP3OlRKq26JvfJDesfEPUJ3N5e9sxZTxtHqxq1xgGo0iqrKEBQ22L1Hjrz9LNaLt7QThx5QaH5wcC59Xv0qDFNVz9ojypf08pfInf0ITmbvvuyfxj3FRpiA2k1bG8Ft8q6JLUaptKlWtQOMABjruTcpVwDHkhL51SqU3ADlNqBdFCUKkuFFhD7j8iWb7zdITTTxrg63C9bViaZzq3TqCY_YZnTWkXk9WAj2XZCHBISGDStDKaVaFoZTBuRt2jEq3YooR0eNPNvsp9dKQyH3MplGhAi4yZTLgesMikBQjOd1DwiLwcXkBByeI-ivG1WCwmoM8Pb6iKLyOPOJa66GlwqIvmGs2z8y-YbMH2Q9e5NHZHd4FYSad6QIUB_qAEkAZmlYvfan31Bbp0eTOXR-5OPT8htnKvuIOkp2VrOV_YZQKulfh6C6A9KyCKR |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Overexpression+of+Adenosine+A2A+Receptors+in+Rats%3A+Effects+on+Depression%2C+Locomotion%2C+and+Anxiety&rft.jtitle=Frontiers+in+psychiatry&rft.au=Coelho%2C+Joana+E&rft.au=Alves%2C+Pedro&rft.au=Canas%2C+Paula+M&rft.au=Valadas%2C+Jorge+S&rft.date=2014&rft.issn=1664-0640&rft.eissn=1664-0640&rft.volume=5&rft.spage=67&rft.epage=67&rft_id=info:doi/10.3389%2Ffpsyt.2014.00067&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-0640&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-0640&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-0640&client=summon |